Charles Diker Insider Sell
According to a legally required document that’s filled with the D.C. based-SEC on 02/10/2015, Charles Diker, Chairman of Cantel Medical Corp and a well informed person, made a sale of 27,415 shares of the firm for around $1,541,943 US Dollars based on an average price per share of $56.2. Charles now owns 4.02 million shares accounting for 10%+ of the Company’s market cap
Cantel Medical Corp Sentiment and Fundamentals
Two of the equity specialist analysts responsible to analyzing the miscellaneous manufacturing’s company’s share, predict an earnings for each share of $1.43 and a Price to Earnings ratio of 39.38 for the fiscal year 2015.
Over the last 200 days, the Cantel Medical Corp’s share price has seen a abrupt increase of 35.26% and is now in a very bullish uptrend. Taking into account Charles’s trade and our momentum model as shown below, we rate Cantel Medical Corp’s stock “neutral”.
As legendary stock market investors such as Bruce Kovner claim, you make the best money through a mix of fundamental & technical analysis. But with this company, it doesn’t look the analysis agree.
Institutional Ownership
Review of 13F filings from SEC show that 158 hedge funds and institutional investors own Cantel Medical Corp. In the last quarter, the company had 81.98% institutional ownership. That is a high interest. They increased by 307,965 the total shares they hold. As of that quarter these institutional investors owned 34.11 million shares. There were 19 funds that closed their positions and 56 that reduced them. A total of 13 funds opened new positions in Cantel Medical Corp and 59 increased their holdings.
Six institutions have this stock in their Top 10. They are: Brown Capital Management Llc, Diker Management Llc, Teton Advisors Inc., Conestoga Capital Advisors Llc, Kimelman & Baird Llc, Geller Family Office Services Llc.
Brown Capital Management Llc is the most bullish institutional investor on Cantel Medical Corp, with ownership of 5.62 million shares as of Q2 2015 for 4.96% of the fund’s portfolio. Mark N. Diker’s Diker Management Llc is another bullish asset manager having 2.05 million shares of the company or 19.24% of their stocks portfolio. The stock is also 16.28% of the fund’s AUM. In addition The New York-based fund Teton Advisors Inc. have 1.94% of their stock portfolio invested in the company’s market cap for 528,005 shares. Conestoga Capital Advisors Llc revealed it had acquired a stake worth 3.65% of the fund’s stock portfolio in Cantel Medical Corp. The New York-based fund Kimelman & Baird Llc is also positive about the public company, possessing 474,285 shares or 4.34% of their stock portfolio.
Cantel Medical Corp NYSE:CMN Company Profile
Cantel Medical Corp is a provider of infection prevention and control products and services. Cantel operates in five segments. Endoscopy includes medical device reprocessing systems, disinfectants, detergents and other supplies used to disinfect flexible endoscopes. Water Purification and Filtration includes water purification equipment and services, filtration and separation products and disinfectants. Healthcare Disposables includes infection prevention and control products. Dialysis includes medical device reprocessing systems, sterilants, dialysate concentrates and other supplies for renal dialysis. Specialty Packaging includes specialty packaging and thermal control products, and related compliance training for the transport of infectious and biological specimens and thermally sensitive pharmaceutical, medical and other products.
Company Website: Cantel Medical Corp
At the moment its market capitalization is: $2.33 billion and it has 41.67 million outstanding shares. Now the company has 84.66% shareholders and the institutional ownership is 84.66%. Cantel Medical Corp has 1534 employees. Cantel Medical Corp was founded in Delaware on 1963-08-16. The stock closed at $56.119999 yesterday and it had average 2 days volume of 41442 shares. It is down from the 30 days average shares volume of 42906. Cantel Medical Corp has a 52w low of $35.21 and a 52 weeks high of $58.00. The current price is above the 200 days simple moving average. Cantel Medical Corp last issued its quarterly earnings information on 09/29/2015. The company reported 0.39 EPS for the quarter, above the consensus estimate of 0.3 by 0.09. The company had a revenue of 151.26 million for 7/31/2015 and 141.51 million for 4/30/2015. Therefore, the revenue was 9.75 million up.
Charles Diker is also director of Loews Corp.
* The per share sale prices ranged from $55.35 to $56.90. Upon request by the Commission staff - the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price.
* The per share sale prices ranged from $56.10 to $57.00. Upon request by the Commission staff - the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price.
